Igwe F[au] - Search Results

Year	Number of Results
1992	1
1999	1
2017	1
2019	1
2020	1
2021	1
2022	2
2023	6
2024	2

1

One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry.

MacCumber MW, Wykoff CC, Karcher H, Adiguzel E, Sinha SB, Vishwakarma S, LaPrise A, Igwe F, Freitas R, Ip MS, Zarbin MA. MacCumber MW, et al. Among authors: igwe f. Ophthalmology. 2023 Sep;130(9):937-946. doi: 10.1016/j.ophtha.2023.04.012. Epub 2023 Apr 21. Ophthalmology. 2023. PMID: 37086857

2

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.

MacCumber MW, Wykoff CC, Karcher H, Adiguzel E, Sinha SB, Vishwakarma S, LaPrise A, Igwe F, Freitas R, Ip MS, Zarbin MA. MacCumber MW, et al. Among authors: igwe f. Ophthalmology. 2023 Aug;130(8):795-803. doi: 10.1016/j.ophtha.2023.03.017. Epub 2023 Mar 27. Ophthalmology. 2023. PMID: 36990322

3

Potential for Treatment Interval Extension in Eyes with nAMD Disease Activity Post Loading Phase in HAWK and HARRIER.

Tadayoni R, Jaffe GJ, Holz FG, Schmidt-Erfurth U, Takahashi K, Cheung CMG, Hariprasad SM, Gedif K, Olsen R, Best C, Igwe F, Kaiser PK. Tadayoni R, et al. Among authors: igwe f. Ophthalmol Ther. 2023 Aug;12(4):2209-2216. doi: 10.1007/s40123-023-00735-8. Epub 2023 Jun 9. Ophthalmol Ther. 2023. PMID: 37294524 Free PMC article.

4

Exploring the role of retinal fluid as a biomarker for the management of diabetic macular oedema.

Khoramnia R, Nguyen QD, Kertes PJ, Sararols Ramsay L, Vujosevic S, Anderesi M, Igwe F, Eter N. Khoramnia R, et al. Among authors: igwe f. Eye (Lond). 2024 Jan;38(1):54-60. doi: 10.1038/s41433-023-02637-2. Epub 2023 Jul 21. Eye (Lond). 2024. PMID: 37479803 Free PMC article. Review.

5

The Treatment Patterns with Brolucizumab in Germany (REALIZE) Study: A Retrospective Cohort Study Based on Longitudinal Prescription Data.

Liegl RG, Karcher H, Chetty-Mhlanga S, Igwe F, Freitas R. Liegl RG, et al. Among authors: igwe f. Ophthalmol Ther. 2023 Feb;12(1):195-208. doi: 10.1007/s40123-022-00596-7. Epub 2022 Nov 3. Ophthalmol Ther. 2023. PMID: 36327000 Free PMC article.

6

Trends in the Cumulative Post-Marketing Reporting Rates of Retinal Vasculitis and/or Retinal Vascular Occlusion and Associated Vision Loss with Brolucizumab.

Igwe F, Lodha A, Ravindran A. Igwe F, et al. Ophthalmol Ther. 2023 Feb;12(1):593-598. doi: 10.1007/s40123-022-00617-5. Epub 2022 Dec 5. Ophthalmol Ther. 2023. PMID: 36469211 Free PMC article.

7

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.

Zarbin MA, MacCumber MW, Karcher H, Adiguzel E, Mayhook A, LaPrise A, Bilano VL, Igwe F, Ip MS, Wykoff CC. Zarbin MA, et al. Among authors: igwe f. Ophthalmol Ther. 2024 Mar 23. doi: 10.1007/s40123-024-00920-3. Online ahead of print. Ophthalmol Ther. 2024. PMID: 38520643

8

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study.

Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F. Gale RP, et al. Among authors: igwe f. Br J Ophthalmol. 2020 Apr;104(4):493-499. doi: 10.1136/bjophthalmol-2019-314251. Epub 2019 Aug 5. Br J Ophthalmol. 2020. PMID: 31383649 Free PMC article. Clinical Trial.

9

Investigating Factors Associated with Immunization Incompletion of Children Under Five in Ebonyi State, Southeast Nigeria: Implication for Policy Dialogue.

Umoke PCI, Umoke M, Nwalieji CA, Igwe FO, Umoke UG, Onwe RN, Nwazunku AA, Nwafor IE, Chukwu OJ, Eyo N, Ugwu A, Ogbonnaya K, Okeke E, Eke DO. Umoke PCI, et al. Among authors: igwe fo. Glob Pediatr Health. 2021 Feb 6;8:2333794X21991008. doi: 10.1177/2333794X21991008. eCollection 2021. Glob Pediatr Health. 2021. PMID: 33614848 Free PMC article.

10

Resource Use and Real-World Outcomes for Ranibizumab Treat and Extend for Neovascular Age-Related Macular Degeneration in the UK: Interim Results from TERRA.

Yang Y, Downey L, Mehta H, Mushtaq B, Narendran N, Patel N, Patel PJ, Ayan F, Gibson K, Igwe F, Jeffery P. Yang Y, et al. Among authors: igwe f. Ophthalmol Ther. 2017 Jun;6(1):175-186. doi: 10.1007/s40123-017-0091-9. Epub 2017 May 15. Ophthalmol Ther. 2017. PMID: 28508241 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year